Cargando…

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023

BACKGROUND: Myocardial ischemia/reperfusion injury (MIRI) refers to the more severe damage that occurs in the previously ischemic myocardium after a short-term interruption of myocardial blood supply followed by restoration of blood flow within a certain period of time. MIRI has become a major chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yifei, Guo, Lijun, Zhang, Zhibo, Fu, Shuangqing, Huang, Pingping, Wang, Anzhu, Liu, Mi, Ma, Xiaochang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293770/
https://www.ncbi.nlm.nih.gov/pubmed/37383699
http://dx.doi.org/10.3389/fcvm.2023.1180792
_version_ 1785063061869035520
author Wang, Yifei
Guo, Lijun
Zhang, Zhibo
Fu, Shuangqing
Huang, Pingping
Wang, Anzhu
Liu, Mi
Ma, Xiaochang
author_facet Wang, Yifei
Guo, Lijun
Zhang, Zhibo
Fu, Shuangqing
Huang, Pingping
Wang, Anzhu
Liu, Mi
Ma, Xiaochang
author_sort Wang, Yifei
collection PubMed
description BACKGROUND: Myocardial ischemia/reperfusion injury (MIRI) refers to the more severe damage that occurs in the previously ischemic myocardium after a short-term interruption of myocardial blood supply followed by restoration of blood flow within a certain period of time. MIRI has become a major challenge affecting the therapeutic efficacy of cardiovascular surgery. METHODS: A scientific literature search on MIRI-related papers published from 2000 to 2023 in the Web of Science Core Collection database was conducted. VOSviewer was used for bibliometric analysis to understand the scientific development and research hotspots in this field. RESULTS: A total of 5,595 papers from 81 countries/regions, 3,840 research institutions, and 26,202 authors were included. China published the most papers, but the United States had the most significant influence. Harvard University was the leading research institution, and influential authors included Lefer David J., Hausenloy Derek J., Yellon Derek M., and others. All keywords can be divided into four different directions: risk factors, poor prognosis, mechanisms and cardioprotection. CONCLUSION: Research on MIRI is flourishing. It is necessary to conduct an in-depth investigation of the interaction between different mechanisms and multi-target therapy will be the focus and hotspot of MIRI research in the future.
format Online
Article
Text
id pubmed-10293770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102937702023-06-28 A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023 Wang, Yifei Guo, Lijun Zhang, Zhibo Fu, Shuangqing Huang, Pingping Wang, Anzhu Liu, Mi Ma, Xiaochang Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Myocardial ischemia/reperfusion injury (MIRI) refers to the more severe damage that occurs in the previously ischemic myocardium after a short-term interruption of myocardial blood supply followed by restoration of blood flow within a certain period of time. MIRI has become a major challenge affecting the therapeutic efficacy of cardiovascular surgery. METHODS: A scientific literature search on MIRI-related papers published from 2000 to 2023 in the Web of Science Core Collection database was conducted. VOSviewer was used for bibliometric analysis to understand the scientific development and research hotspots in this field. RESULTS: A total of 5,595 papers from 81 countries/regions, 3,840 research institutions, and 26,202 authors were included. China published the most papers, but the United States had the most significant influence. Harvard University was the leading research institution, and influential authors included Lefer David J., Hausenloy Derek J., Yellon Derek M., and others. All keywords can be divided into four different directions: risk factors, poor prognosis, mechanisms and cardioprotection. CONCLUSION: Research on MIRI is flourishing. It is necessary to conduct an in-depth investigation of the interaction between different mechanisms and multi-target therapy will be the focus and hotspot of MIRI research in the future. Frontiers Media S.A. 2023-06-13 /pmc/articles/PMC10293770/ /pubmed/37383699 http://dx.doi.org/10.3389/fcvm.2023.1180792 Text en © 2023 Wang, Guo, Zhang, Fu, Huang, Wang, Liu and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wang, Yifei
Guo, Lijun
Zhang, Zhibo
Fu, Shuangqing
Huang, Pingping
Wang, Anzhu
Liu, Mi
Ma, Xiaochang
A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title_full A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title_fullStr A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title_full_unstemmed A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title_short A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
title_sort bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293770/
https://www.ncbi.nlm.nih.gov/pubmed/37383699
http://dx.doi.org/10.3389/fcvm.2023.1180792
work_keys_str_mv AT wangyifei abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT guolijun abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT zhangzhibo abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT fushuangqing abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT huangpingping abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT wanganzhu abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT liumi abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT maxiaochang abibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT wangyifei bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT guolijun bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT zhangzhibo bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT fushuangqing bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT huangpingping bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT wanganzhu bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT liumi bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023
AT maxiaochang bibliometricanalysisofmyocardialischemiareperfusioninjuryfrom2000to2023